A comprehensive systematic review and dose-response meta-analysis published in The Lancet, analyzing 57 studies across 35 cohorts, has found that walking approximately 7,000 steps daily is associated with multiple favorable health outcomes. This threshold offers nearly the same benefits as the traditionally recommended 10,000 steps, significantly reducing risks of early death, cardiovascular disease, dementia, depression, cancer, and diabetes. Compared to walking 2,000 steps per day, achieving 7,000 steps reduces cardiovascular disease risk by 25%, dementia by 38%, depression by 22%, and cancer by 6%. The study challenges the widely held belief that 10,000 steps is the optimal daily target, noting that the 10,000-step goal originated as a marketing concept during the 1964 Tokyo Olympics and lacks a solid scientific basis. Researchers emphasize that even modest increases in daily steps below 10,000 can deliver substantial health benefits and that 7,000 steps is a more achievable and practical target for many individuals. The findings have been highlighted globally and reported by multiple outlets, underscoring the potential for public health guidelines to be updated to reflect this evidence.